4 takeaways from Tuesday’s Senate drug pricing hearing
Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.
Legislation
Live blog: Pharma execs on the Hill
The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.
Cassidy, Warner draft bill to promote value-based payment models
Senators Bill Cassidy and Mark Warner are taking feedback from the public before introducing the bill.
Bill to end tax exemption for pharma marketing introduced in Senate
Sixteen Democratic senators are backing the latest version of a bill to end the exemption for DTC advertising.
Democratic senator: Constituents want bipartisanship, healthcare transparency
Sen. Christopher Coons (D-DE) talked healthcare priorities at the Coalition for Healthcare Communication post-election conference in Washington D.C. on Monday.
4 expert takes on what the midterms mean for pharma
MM&M asked experts to predict what the next two years could hold for pharma- and healthcare-related legislation.
Five things for pharma marketers to know: Friday, January 19, 2018
Biogen, UCB reportedly showing interest in Acorda acquisition; Kite Pharma and Pfizer to develop combo lymphoma therapy; hospitals to form generics nonprofit
NORML balances federal, local action after Cole memo reversal
Once Attorney General Jeff Sessions reversed the Cole memo, NORML began applying pressure both locally and nationally for changes in marijuana laws.
Five things for pharma marketers to know: Thursday, July 13, 2017
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
DTC Report 2016: Gut Check
DTC is facing a new test from physicians and politicians. Here’s why critics fear a deluge, and how they’re pushing back.
